APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Doxorubicin Liposome Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Doxorubicin Liposome Injection Industry Growth and Trends Forecast to 2032

Report ID 173985890128 December 202578 pages

Choose your research edition.

Industry ResearchDoxorubicin Liposome Injection Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Doxorubicin Liposome Injection Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Doxorubicin Liposome Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Doxorubicin Liposome Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Doxorubicin Liposome Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Doxorubicin Liposome Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Doxorubicin Liposome Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Doxorubicin Liposome Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Doxorubicin Liposome Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Doxorubicin Liposome Injection include Baxter and Dr. Reddy's Laboratories among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Doxorubicin Liposome Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Doxorubicin Liposome Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Doxorubicin Liposome Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Doxorubicin Liposome Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Doxorubicin Liposome Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Doxorubicin Liposome Injection Market by Company

Baxter

Dr. Reddy's Laboratories

Doxorubicin Liposome Injection Segment by Type

10ml/vial

50ml/vial

5ml/vial

Doxorubicin Liposome Injection Segment by Application

Hospital

Clinic

Others

Doxorubicin Liposome Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Doxorubicin Liposome Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Doxorubicin Liposome Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Doxorubicin Liposome Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Doxorubicin Liposome Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Doxorubicin Liposome Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10ml/vial Table 2. Major Company of 50ml/vial Table 3. Major Company of 5ml/vial Table 4. Global Doxorubicin Liposome Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Doxorubicin Liposome Injection Sales by Type (2021-2026) & (K Units) Table 6. Global Doxorubicin Liposome Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Doxorubicin Liposome Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Doxorubicin Liposome Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Doxorubicin Liposome Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Doxorubicin Liposome Injection Sales by Type (2027-2032) & (K Units) Table 11. Global Doxorubicin Liposome Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Doxorubicin Liposome Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Doxorubicin Liposome Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Doxorubicin Liposome Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Doxorubicin Liposome Injection Sales by Type (2021-2026) & (K Units) Table 16. North America Doxorubicin Liposome Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Doxorubicin Liposome Injection Sales by Type (2021-2026) & (K Units) Table 18. Europe Doxorubicin Liposome Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Doxorubicin Liposome Injection Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Doxorubicin Liposome Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Doxorubicin Liposome Injection Sales by Type (2021-2026) & (K Units) Table 22. Latin America Doxorubicin Liposome Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Doxorubicin Liposome Injection Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Doxorubicin Liposome Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Doxorubicin Liposome Injection Industry Trends Table 26. Doxorubicin Liposome Injection Industry Drivers Table 27. Doxorubicin Liposome Injection Industry Opportunities and Challenges Table 28. Doxorubicin Liposome Injection Industry Restraints Table 29. Global Doxorubicin Liposome Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Doxorubicin Liposome Injection Revenue Market Share by Company (2021-2026) Table 31. Global Doxorubicin Liposome Injection Sales by Company (2021-2026) & (K Units) Table 32. Global Doxorubicin Liposome Injection Sales Share by Company (2021-2026) Table 33. Global Doxorubicin Liposome Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Doxorubicin Liposome Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Doxorubicin Liposome Injection Major Company Production Sites and Headquarters Table 36. Global Doxorubicin Liposome Injection Company, Product Type & Application Table 37. Global Doxorubicin Liposome Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Doxorubicin Liposome Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Doxorubicin Liposome Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Doxorubicin Liposome Injection Sales by Region (2021-2026) & (K Units) Table 42. Global Doxorubicin Liposome Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Doxorubicin Liposome Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Doxorubicin Liposome Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Doxorubicin Liposome Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Doxorubicin Liposome Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Doxorubicin Liposome Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Doxorubicin Liposome Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Doxorubicin Liposome Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Doxorubicin Liposome Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Doxorubicin Liposome Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Doxorubicin Liposome Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Doxorubicin Liposome Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Doxorubicin Liposome Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Doxorubicin Liposome Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Doxorubicin Liposome Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Doxorubicin Liposome Injection Sales by Application (2027-2032) & (K Units) Table 58. Global Doxorubicin Liposome Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Doxorubicin Liposome Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Doxorubicin Liposome Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Doxorubicin Liposome Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Doxorubicin Liposome Injection Sales by Application (2021-2026) & (K Units) Table 63. North America Doxorubicin Liposome Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Doxorubicin Liposome Injection Sales by Application (2021-2026) & (K Units) Table 65. Europe Doxorubicin Liposome Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Doxorubicin Liposome Injection Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Doxorubicin Liposome Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Doxorubicin Liposome Injection Sales by Application (2021-2026) & (K Units) Table 69. Latin America Doxorubicin Liposome Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Doxorubicin Liposome Injection Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Doxorubicin Liposome Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Baxter Company Information Table 73. Baxter Business Overview Table 74. Baxter Doxorubicin Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Baxter Doxorubicin Liposome Injection Product Portfolio Table 76. Baxter Recent Development Table 77. Dr. Reddy's Laboratories Company Information Table 78. Dr. Reddy's Laboratories Business Overview Table 79. Dr. Reddy's Laboratories Doxorubicin Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Dr. Reddy's Laboratories Doxorubicin Liposome Injection Product Portfolio Table 81. Dr. Reddy's Laboratories Recent Development Table 82. North America Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 83. North America Doxorubicin Liposome Injection Sales by Country (2021-2026) & (K Units) Table 84. North America Doxorubicin Liposome Injection Sales Market Share by Country (2021-2026) Table 85. North America Doxorubicin Liposome Injection Sales Forecast by Country (2027-2032) & (K Units) Table 86. North America Doxorubicin Liposome Injection Sales Market Share Forecast by Country (2027-2032) Table 87. North America Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 88. North America Doxorubicin Liposome Injection Market Size by Country (2021-2026) & (US$ Million) Table 89. North America Doxorubicin Liposome Injection Market Share by Country (2021-2026) Table 90. North America Doxorubicin Liposome Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 91. North America Doxorubicin Liposome Injection Market Share Forecast by Country (2027-2032) Table 92. Europe Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. Europe Doxorubicin Liposome Injection Sales by Country (2021-2026) & (K Units) Table 94. Europe Doxorubicin Liposome Injection Sales Market Share by Country (2021-2026) Table 95. Europe Doxorubicin Liposome Injection Sales Forecast by Country (2027-2032) & (K Units) Table 96. Europe Doxorubicin Liposome Injection Sales Market Share Forecast by Country (2027-2032) Table 97. Europe Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. Europe Doxorubicin Liposome Injection Market Size by Country (2021-2026) & (US$ Million) Table 99. Europe Doxorubicin Liposome Injection Market Share by Country (2021-2026) Table 100. Europe Doxorubicin Liposome Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. Europe Doxorubicin Liposome Injection Market Share Forecast by Country (2027-2032) Table 102. Asia-Pacific Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Asia-Pacific Doxorubicin Liposome Injection Sales by Country (2021-2026) & (K Units) Table 104. Asia-Pacific Doxorubicin Liposome Injection Sales Market Share by Country (2021-2026) Table 105. Asia-Pacific Doxorubicin Liposome Injection Sales Forecast by Country (2027-2032) & (K Units) Table 106. Asia-Pacific Doxorubicin Liposome Injection Sales Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Doxorubicin Liposome Injection Market Size by Country (2021-2026) & (US$ Million) Table 109. Asia-Pacific Doxorubicin Liposome Injection Market Share by Country (2021-2026) Table 110. Asia-Pacific Doxorubicin Liposome Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Asia-Pacific Doxorubicin Liposome Injection Market Share Forecast by Country (2027-2032) Table 112. Latin America Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Latin America Doxorubicin Liposome Injection Sales by Country (2021-2026) & (K Units) Table 114. Latin America Doxorubicin Liposome Injection Sales Market Share by Country (2021-2026) Table 115. Latin America Doxorubicin Liposome Injection Sales Forecast by Country (2027-2032) & (K Units) Table 116. Latin America Doxorubicin Liposome Injection Sales Market Share Forecast by Country (2027-2032) Table 117. Latin America Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Latin America Doxorubicin Liposome Injection Market Size by Country (2021-2026) & (US$ Million) Table 119. Latin America Doxorubicin Liposome Injection Market Share by Country (2021-2026) Table 120. Latin America Doxorubicin Liposome Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Latin America Doxorubicin Liposome Injection Market Share Forecast by Country (2027-2032) Table 122. Middle East and Africa Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Middle East and Africa Doxorubicin Liposome Injection Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Doxorubicin Liposome Injection Sales Market Share by Country (2021-2026) Table 125. Middle East and Africa Doxorubicin Liposome Injection Sales Forecast by Country (2027-2032) & (K Units) Table 126. Middle East and Africa Doxorubicin Liposome Injection Sales Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Doxorubicin Liposome Injection Market Size by Country (2021-2026) & (US$ Million) Table 129. Middle East and Africa Doxorubicin Liposome Injection Market Share by Country (2021-2026) Table 130. Middle East and Africa Doxorubicin Liposome Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Middle East and Africa Doxorubicin Liposome Injection Market Share Forecast by Country (2027-2032) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Doxorubicin Liposome Injection Distributors List Table 135. Doxorubicin Liposome Injection Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Doxorubicin Liposome Injection Image Figure 2. Global Doxorubicin Liposome Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Doxorubicin Liposome Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Doxorubicin Liposome Injection Sales (2021-2032) & (K Units) Figure 5. 10ml/vial Image Figure 6. Global 10ml/vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 50ml/vial Image Figure 8. Global 50ml/vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. 5ml/vial Image Figure 10. Global 5ml/vial Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Doxorubicin Liposome Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Doxorubicin Liposome Injection Market Share by Type 2025 VS 2032 Figure 13. North America Doxorubicin Liposome Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Doxorubicin Liposome Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Doxorubicin Liposome Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Doxorubicin Liposome Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Doxorubicin Liposome Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Doxorubicin Liposome Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Doxorubicin Liposome Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Doxorubicin Liposome Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Doxorubicin Liposome Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Doxorubicin Liposome Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Doxorubicin Liposome Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Doxorubicin Liposome Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Doxorubicin Liposome Injection Market Share by Application 2025 VS 2032 Figure 33. North America Doxorubicin Liposome Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Doxorubicin Liposome Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Doxorubicin Liposome Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Doxorubicin Liposome Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Doxorubicin Liposome Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Doxorubicin Liposome Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Doxorubicin Liposome Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Doxorubicin Liposome Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Doxorubicin Liposome Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Doxorubicin Liposome Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Doxorubicin Liposome Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Doxorubicin Liposome Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Doxorubicin Liposome Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Doxorubicin Liposome Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Doxorubicin Liposome Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Doxorubicin Liposome Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Doxorubicin Liposome Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Doxorubicin Liposome Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Doxorubicin Liposome Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Doxorubicin Liposome Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Doxorubicin Liposome Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Doxorubicin Liposome Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Doxorubicin Liposome Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Doxorubicin Liposome Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Doxorubicin Liposome Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Doxorubicin Liposome Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Doxorubicin Liposome Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Doxorubicin Liposome Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Doxorubicin Liposome Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Doxorubicin Liposome Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Doxorubicin Liposome Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Doxorubicin Liposome Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml/vial
  • 50ml/vial
  • 5ml/vial
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Baxter
  • Dr. Reddy's Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Doxorubicin Liposome Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Doxorubicin Liposome Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Doxorubicin Liposome Injection Market by Type
  6. 1.3.1 10ml/vial
  7. 1.3.2 50ml/vial
  8. 1.3.3 5ml/vial
  9. 1.4 Global Doxorubicin Liposome Injection Market Size by Type
  10. 1.4.1 Global Doxorubicin Liposome Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Doxorubicin Liposome Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Doxorubicin Liposome Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Doxorubicin Liposome Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Doxorubicin Liposome Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Doxorubicin Liposome Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Doxorubicin Liposome Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Doxorubicin Liposome Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Doxorubicin Liposome Injection Industry Trends
  2. 2.2 Doxorubicin Liposome Injection Industry Drivers
  3. 2.3 Doxorubicin Liposome Injection Industry Opportunities and Challenges
  4. 2.4 Doxorubicin Liposome Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Doxorubicin Liposome Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Doxorubicin Liposome Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Doxorubicin Liposome Injection Price (2021-2026)
  4. 3.4 Global Doxorubicin Liposome Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Doxorubicin Liposome Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Doxorubicin Liposome Injection Company, Product Type & Application
  7. 3.7 Global Doxorubicin Liposome Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Doxorubicin Liposome Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Doxorubicin Liposome Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Doxorubicin Liposome Injection Tier 1, Tier 2, and Tier 3
4 Doxorubicin Liposome Injection Regional Status and Outlook
  1. 4.1 Global Doxorubicin Liposome Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Doxorubicin Liposome Injection Historic Market Size by Region
  3. 4.2.1 Global Doxorubicin Liposome Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Doxorubicin Liposome Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Doxorubicin Liposome Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Doxorubicin Liposome Injection Forecasted Market Size by Region
  7. 4.3.1 Global Doxorubicin Liposome Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Doxorubicin Liposome Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Doxorubicin Liposome Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Doxorubicin Liposome Injection by Application
  1. 5.1 Doxorubicin Liposome Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Doxorubicin Liposome Injection Market Size by Application
  6. 5.2.1 Global Doxorubicin Liposome Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Doxorubicin Liposome Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Doxorubicin Liposome Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Doxorubicin Liposome Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Doxorubicin Liposome Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Doxorubicin Liposome Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Doxorubicin Liposome Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Doxorubicin Liposome Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baxter
  2. 6.1.1 Baxter Company Information
  3. 6.1.2 Baxter Business Overview
  4. 6.1.3 Baxter Doxorubicin Liposome Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baxter Doxorubicin Liposome Injection Product Portfolio
  6. 6.1.5 Baxter Recent Developments
  7. 6.2 Dr. Reddy's Laboratories
  8. 6.2.1 Dr. Reddy's Laboratories Company Information
  9. 6.2.2 Dr. Reddy's Laboratories Business Overview
  10. 6.2.3 Dr. Reddy's Laboratories Doxorubicin Liposome Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dr. Reddy's Laboratories Doxorubicin Liposome Injection Product Portfolio
  12. 6.2.5 Dr. Reddy's Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Doxorubicin Liposome Injection Sales by Country
  2. 7.1.1 North America Doxorubicin Liposome Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Doxorubicin Liposome Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Doxorubicin Liposome Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Doxorubicin Liposome Injection Market Size by Country
  6. 7.2.1 North America Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Doxorubicin Liposome Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Doxorubicin Liposome Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Doxorubicin Liposome Injection Sales by Country
  2. 8.1.1 Europe Doxorubicin Liposome Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Doxorubicin Liposome Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Doxorubicin Liposome Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Doxorubicin Liposome Injection Market Size by Country
  6. 8.2.1 Europe Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Doxorubicin Liposome Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Doxorubicin Liposome Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Doxorubicin Liposome Injection Sales by Country
  2. 9.1.1 Asia-Pacific Doxorubicin Liposome Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Doxorubicin Liposome Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Doxorubicin Liposome Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Doxorubicin Liposome Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Doxorubicin Liposome Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Doxorubicin Liposome Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Doxorubicin Liposome Injection Sales by Country
  2. 10.1.1 South America Doxorubicin Liposome Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Doxorubicin Liposome Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Doxorubicin Liposome Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Doxorubicin Liposome Injection Market Size by Country
  6. 10.2.1 South America Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Doxorubicin Liposome Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Doxorubicin Liposome Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Doxorubicin Liposome Injection Sales by Country
  2. 11.1.1 Middle East and Africa Doxorubicin Liposome Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Doxorubicin Liposome Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Doxorubicin Liposome Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Doxorubicin Liposome Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Doxorubicin Liposome Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Doxorubicin Liposome Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Doxorubicin Liposome Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Doxorubicin Liposome Injection Value Chain Analysis
  2. 12.1.1 Doxorubicin Liposome Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Doxorubicin Liposome Injection Production Mode & Process
  7. 12.2 Doxorubicin Liposome Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Doxorubicin Liposome Injection Distributors
  10. 12.2.3 Doxorubicin Liposome Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst